Edwards Lifesciences (EW, Financial) saw its stock surge by 5%, trading at $67.77 per share with a volume of 2.42 million shares. The stock witnessed a turnover rate of 0.40% and a price fluctuation of 5.02%. Recent earnings reports revealed revenue of $1.386 billion and a net profit of $368 million, resulting in earnings of $0.61 per share and a gross profit of $1.088 billion. The company's price-to-earnings ratio is 27.88.
In terms of institutional ratings, out of 33 firms covering the stock, 45% recommended a buy, 52% recommended holding, and 3% advised selling. Within the medical device sector, which rose by 0.80%, stocks like Spectral Ai Inc, Trinity Biotech Plc, and Inspira Tech Oxy Bhn Ltd showed significant gains. Meanwhile, Tenon Medical, Bluejay Diagnostics, and Vivos Therapeutics displayed notable trading activity. Stocks with large price swings included Dih Holding Us Inc, Icecure Medical Ltd, and Spectral Ai Inc.
Edwards Lifesciences, spun off from Baxter International in 2000, specializes in designing, manufacturing, and selling medical devices for advanced structural heart disease. It is a leader in key products such as surgical tissue heart valves and transcatheter valve technologies, with approximately 55% of its sales generated outside the U.S.
